GSK’s asthma blockbuster Nucala secures win in COPD Phase III trial
GSK is adding more strings to Nucala’s bow as the drug’s sales continue to grow.
![](https://www.clinicaltrialsarena.com/wp-content/uploads/sites/22/2024/09/shutterstock_2409447781.jpg)
GSK is adding more strings to Nucala’s bow as the drug’s sales continue to grow.
Representatives of the WHO and the IFRC called for international cooperation to tackle the current mpox outbreak.
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms,...
Ultromics’s EchoGo misses primary endpoint in heart disease trial
NHS report touts effectiveness of Skin Analytics’ DERM AI melanoma tool
Spectral AI hits enrollment goal at burn centres for AI-powered assessment tech
What is mpox and how big of a threat is it?